Bupropion
Also known as: Wellbutrin, Zyban, bupropion hydrochloride
Classification
Pharmaceutical
Regulatory Status
FDA-approved prescription product or labeled drug class
Sources
1
Review
n/a
Overview
Bupropion is represented by its commonly described norepinephrine dopamine reuptake inhibitor mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
norepinephrine dopamine reuptake inhibitor
Benefits
FDA-approved aminoketone antidepressant used for major depressive disorder and seasonal affective disorder, and as an aid to smoking cessation (product-specific labels such as Wellbutrin and Zyban families).
Interactions & cautions
Flagged in source data
Drug interactions
monoamine oxidase inhibitors — Contraindicated due to hypertensive reaction risk. (high)
CYP2D6 substrates and strong CYP2B6 modulators — Bupropion inhibits CYP2D6 and is metabolized via CYP2B6—exposure changes may be clinically important. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw